• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Swelling (2091)
Event Date 06/07/2019
Event Type  Injury  
Manufacturer Narrative
Initial reporter city: (b)(6).
 
Event Description
It was reported that the patient experienced fever and swelling of the legs.A 6x80, 130 cm eluvia drug-eluting vascular stent system was selected for a patient procedure.The stent was implanted in the mid left superficial femoral artery (sfa) on (b)(6) 2019.The patient then complained of fever and swelling of the legs four days later.The procedure was performed from the right common femoral artery by contralateral approach.A non-bsc sheath was advanced to the origin part of the left sfa, and a jupiterfc3 guidewire crossed the lesion.After that, a measurement was performed in the blood vessel with ivus and size selection of a pre-balloon and eluvia was performed.The blood vessel diameter was about 5.8 mm.The pre-balloon used was an unspecified 5mm.After pre-ballooning the lesion, the guidewire was replaced with non-bsc guidewire, and eluvia was placed.There was nothing unusual about the placement.The guidewire was replaced with jupiterfc3, and post-balloon was performed by an unspecified 5mm balloon.The status of the stent was checked by ivus, and the procedure was completed.The physician does not think eluvia is the cause of the fever and swelling of the legs.No further complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key8744427
MDR Text Key149511066
Report Number2134265-2019-07554
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 06/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/28/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/19/2020
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023104787
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/07/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/20/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DESTINATION SHEATH; RADIFOCUS GUIDEWIRE
Patient Outcome(s) Other;
-
-